Goldman Small Cap Research Issues Research Update on Catalyst Pharmaceutical Partners, Inc.

Published July 17, 2010

Goldman Small Cap Research Issues Research Update on Catalyst Pharmaceutical Partners, Inc.
BALTIMORE — Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, has released a research update on Catalyst Pharmaceutical Partners, Inc. , a biopharmaceutical company focused on the commercialization of drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy.
Read more on GlobeNewswire via Yahoo! Finance